SCHEMBL7296313

SCHEMBL7296313

COc1ccc2c(c1)CCC(C(=O)O)O2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.51
PPARA Q07869 1/20 0.51
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
CYP4F2 P78329 5/20 0.47
CYP4A11 Q02928 5/20 0.47
GABRA1 P14867 1/20 0.47
GABRB2 P47870 1/20 0.47
GLS O94925 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
MTNR1A P48039 2/20 0.45
MTNR1B P49286 1/20 0.45
ALDH1A1 P00352 1/20 0.45
POLB P06746 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
LTB4R Q15722 1/20 0.45
LTB4R2 Q9NPC1 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7296319 1.00 PPARG (0.51) PPARGPPARANFKB1NFKB2RELA
SCHEMBL7320224 0.89 PPARG (0.51) PPARGPPARANFKB1NFKB2RELA
SCHEMBL7320221 0.89 PPARG (0.51) PPARGPPARANFKB1NFKB2RELA
SCHEMBL7320228 0.89 PPARG (0.51) PPARGPPARANFKB1NFKB2RELA
SCHEMBL9254934 0.87 PPARG (0.53) PPARGPPARANFKB1NFKB2RELA
SCHEMBL7289417 0.85 GLS (0.57) GABRA1GABRB2GLSMEN1KMT2A
SCHEMBL7290004 0.85 GLS (0.57) GABRA1GABRB2GLSMEN1KMT2A
SCHEMBL7289411 0.85 GLS (0.57) GABRA1GABRB2GLSMEN1KMT2A
SCHEMBL11523391 0.83 PPARG (0.65) PPARGPPARANFKB1NFKB2RELA
SCHEMBL433940 0.81 CYP4F2 (0.50) PPARGPPARANFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6359138-B1 CENTRAL NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. 2002-03-19 US disclosed
EP-0846683-B1 4-Hydroxy-piperidine derivatives HOFFMANN LA ROCHE (CH) 2001-09-19 EP disclosed
EP-0846683-A1 4-Hydroxy-piperidine derivatives F. HOFFMANN-LA ROCHE AG (CH) 1998-06-10 EP disclosed
EP-0145067-B1 DERIVATIVES OF 2,2'-IMINOBISETHANOL JANSSEN PHARMACEUTICA N.V. (BE) 1989-01-25 EP disclosed
US-4654362-A CARDIOVASCULAR DISORDERS JANSSEN PHARMACEUTICA, N.V. (BE) 1987-03-31 US disclosed
EP-0145067-A2 Derivatives of 2,2'-iminobisethanol JANSSEN PHARMACEUTICA N.V. (BE) 1985-06-19 EP disclosed